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Abstract
Background: Wounds in the nonglabrous skin of keloid-prone individuals tend to cause large
disordered accumulations of collagen which extend beyond the original margins of the wound. In
addition to abnormalities in keloid fibroblasts, comparison of dermal fibroblasts derived from
nonwounded glabrous or nonglabrous skin revealed differences that may account for the observed
location of keloids.
Methods: Fibroblast apoptosis and the cellular content of α-smooth-muscle actin, TGFβ1
receptorII and ED-A fibronectin were estimated by FACS analysis. The effects of TGFβ1 and serum
were examined.
Results: In monolayer cultures non-glabrous fibroblasts were slower growing, had higher
granularity and accumulated more α-smooth-muscle actin than fibroblasts from glabrous tissues.
Keloid fibroblasts had the highest level of α-smooth-muscle actin in parallel with their expression
level of ED-A fibronectin. TGFβ1 positively regulated α-smooth-muscle actin expression in all
fibroblast cultures, although its effects on apoptosis in fibroblasts from glabrous and non-glabrous
tissues were found to differ. The presence of collagen I in the ECM resulted in reduction of α-
smooth-muscle actin. A considerable percentage of the apoptotic fibroblasts in attached gels were
α-smooth-muscle actin positive. The extent of apoptosis correlated positively with increased cell
and matrix relaxation. TGFβ1 was unable to overcome this apoptotic effect of matrix relaxation.
Conclusion: The presence of myofibroblasts and the apoptosis level can be regulated by both
TGFβ1 and by the extracellular matrix. However, reduction of tension in the matrix is the critical
determinant. This predicts that the tension in the wound bed determines the type of scar at
different body sites.
Background
Normal wound healing requires fibroblast proliferation
and migration into the wound bed followed by tightly
regulated matrix deposition and contraction. Aberrations
in these processes can lead to excessive collagen accumu-
lation as found in keloids. These scars extend beyond the
original wound margins and are excluded from glabrous
surfaces (palms, soles). When grown in vitro keloid fi-
broblast cultures contain a high percentage of α-smooth
muscle actin (α-SMA) expressing cells – myofibroblasts.
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tion remains obscure [1–11]. However, as TGFβ1 regu-
lates the expression and deposition of collagenous
extracellular matrix (ECM) [12–14] it is expected that kel-
oids develop due to aberrant responses to this cytokine.
While in vitro analyses of TGFβ1 levels in keloid and nor-
mal fibroblasts have yielded variable results [15–20],
higher levels of TGFβ1 receptors and Smad3 activation
were recently reported in keloid fibroblasts [21]. Thus,
procedures that lower TGFβ1 expression may help prevent
keloid development [15,16,18,22].
TGFβ1 also supports the differentiation of fibroblasts into
myofibroblasts, which are a major constituent of the gran-
ulation tissue [23,24]. The process depends upon the de-
formability of the ECM [17,25] and is mediated by the
ED-A splice variant of fibronectin [26,27]. ED-A fibronec-
tin is expressed in the initial stages of wound healing and
along with collagen I is positively regulated by TGFβ1
[26].
Progression of granulation tissue to neodermis requires a
decrease in cellularity through apoptosis of endothelial
cells, fibroblasts and myofibroblasts [28,29]. Keloid fi-
broblasts demonstrate aberrant apoptotic behavior
[30,31] although studies have given variable results
[5,9,11,30–35]. Our initial data for serum-starvation-in-
duced apoptosis in monolayer cultures of dermal fibrob-
lasts demonstrated delayed apoptosis of keloid fibroblasts
and a negative correlation with α-SMA expression [36].
Similar correlations were observed in rat lung fibroblasts,
where TGFβ1 increased α-SMA content while acting as an
antiapoptotic agent [37,38]. It should be noted however,
that many of the myofibroblasts were still able to undergo
apoptosis consistent with in vivo data on palatal wound
healing [39]. Thus, TGFβ1 can promote both α-SMA ex-
pression in the initial stages of wound healing and apop-
tosis in later stages of wound healing. The latter effect may
be related to the apoptosis induced by relaxation of the
ECM or of the collagen gel [40,41].
In order to follow both the differentiation of fibroblasts
into myofibroblasts and their apoptosis in relation to the
tension in the surrounding ECM, we utilized two-color
FACS analyses. Experiments were carried out with human
dermal fibroblasts of different origins – keloid, nonaffect-
ed palmar sites of the corresponding patients, normal fi-
broblasts from palms, heels or nonpalmoplantar sites. α-
SMA content and apoptosis were evaluated as a function
of serum, TGFβ1 and collagen type I. The observed pheno-
typic differences between fibroblasts grown from glabrous
vs. nonglabrous tissue suggest a reason for the exclusion
of keloids from specific body sites of keloid prone individ-
uals.
Methods
Cell growth, media, collagen coating and embedding in 
rafts
Skin samples from palmoplantar (PP) and non-PP loci
were obtained under IRB approval from African-American
keloid prone and normal donors [36]. Biopsies were
rinsed with PBS, minced into small fragments and epider-
mis separated from dermis using a 4°C overnight incuba-
tion with Dispase II (2.5 mg/ml in DMEM). The
epidermis was then removed with forceps and the dermal
pieces were incubated with Collagenase D (3 mg/ml in
collagenase buffer (see below)) for 15–30 min at 37°C. Any
cells and pieces were collected by centrifugation and re-
suspended in trypsin/EDTA (0.5 mg/ml trypsin and 0.25
mM EDTA in PBS) for an additional 15–30 min at 37°C
with occasional shaking. Fetal bovine serum 10% was
added at the end to neutralize the trypsin. Cells were har-
vested by centrifugation (800 rpm in a clinical centrifuge)
and were grown and serially passaged as previously de-
scribed [36]. For experiments, cells from passages four to
six were used with an initial plating density of 10–20
cells/mm2. When added, ascorbic acid and TGFβ1 (R&D
Systems) were used at 50µg/ml and 10 ng/ml, respective-
ly. Fetal bovine serum(Hyclone) 10% was used as supple-
ment to the media (low glucose DMEM (GIBCO, BRL))
when indicated.
Collagen type I coated plates were prepared by incubating
tissue culture plates with 0.1 mg rat tail collagen per ml
Phosphate Buffered Saline (PBS) for 3 hrs at room tem-
perature, followed by a 30 min, 37°C incubation with
0.5%BSA (bovine serum albumin) in PBS with 0.5 mM
Ethylene DiamineTetraacetic acid (EDTA) – PBS/EDTA,
and final PBS washes.
Collagen gels (1.5 mg/ml) were prepared with fibroblasts
harvested at confluence and resuspended to 106 cells/ml
collagen solution (see also [36]). One ml of this cell sus-
pension was added per well of a 6 well plate (Nunc). Gel
relaxation was achieved by full detachment with a spatula.
Gels with keloid fibroblasts tend to shrink, but remain at-
tached to the center of the well. To harvest cells the gels
were first incubated with 100 µl trypsin/EDTA (0.5 mg/ml
trypsin;.0.25 mM EDTA) for 10 min at 37°C, and then
with 400 µl collagenase D (5 mg/ml; Boehringer) in colla-
genase buffer (20 mM Hepes pH 7, 0.13 mM NaCl, 10 mM
Ca Acetate) for 30 min at 37°C. The reaction was stopped
by addition of fetal bovine serum to 10%. Cells were col-
lected by centrifugation at 2000 rpm and the resultant pel-
let was washed with PBS.
3H-Thymidine incorporation
Fibroblasts at 70% confluence were incubated for 4 hrs in
serum-free DMEM containing 4 µCi/ml methyl- 3H-thy-
midine (87 Ci/mmol) (NEN, Boston, MA). The cells werePage 2 of 13
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1 hr in 10% tri-chloro-acetic acid (TCA) on ice. They were
then applied to a glass filter (Whatman GF/C glass micro-
fibre) and washed in a filter assembly (Sigma) with
10%TCA and once with 95% ethanol, before being dried
and counted in an LKB liquid scintillation counter. The
cell number was determined by direct counting. The data
were an average of three experiments.
Preparation and performance of the FACS analysis
For each FACS assay about one million cells were fixed by
suspension in the non-formaldehyde tissue fixative Histo-
Choice (Amresco, Ohio) for 20-minute at room tempera-
ture. For permeabilization cells were treated for 3 min at
4°C with 0.3% Triton in PBS. The ED-A antibody gave
nearly identical results for permeabilized and nonperme-
abilized cells.
Apoptosis levels were measured using the TUNEL assay
(Boehringer – In Situ Cell Death Detection Kit, Fluores-
cein) according to manufacturer's recommendations on
cells, which were resuspended in 50 µl reaction mix and
incubated for 1 hr at 37°C with regular agitation. After two
PBS washes cells were resuspended in PBS and incubated
with the primary antibody.
The primary antibodies against human α-SMA (mono-
clonal Asm-1, Roche Molecular Biochemicals), TGFβ1
(pan specific, produced in rabbits, R&D systems), ED-A fi-
bronectin (MAS 521, Accurate Chemicals, Westbury, NY);
and TGFβ1 receptor II (affinity purified rabbit polyclonal,
H-657, Santa Cruz Biotechnology Inc.) were diluted
1:100. The secondary antibodies – FITC and Phycoeryth-
rin (PE) – conjugated IgG (Jackson ImmunoResearch
Labs) were used at 1:100 dilutions. Incubations with anti-
bodies (primary and secondary) were all carried out for
one hour at room temperature with several PBS washes in
between.
The samples were filtered through 35 µm cell strainer caps
of Falcon polystyrene tubes before being applied to a
Beckton Dickinson Fascan equipped with CellQuest soft-
ware version 3.2. Controls included cells incubated only
with the secondary antibody, cells incubated only with
the primary antibodies, cells after the TUNEL reaction on-
ly, and cells without the TUNEL reaction. These controls
were used to determine the settings for the FACS analyses.
The background fluorescence had values around 20–30 in
arbitrary fluorescence units for all of the controls. Cells
with fluorescence above this value were considered im-
munopositive and/or apoptotic.
The results of the FACS analyses are presented using a
combined measure of both percentage immunopositive/
apoptotic cells (with fluorescence above the background)
and their GeoMean fluorescence: [% immuno-positive or
apoptotic cells]* [GeoMean-background fluorescence].
(For more details, please, see additional file 5: Appendix
to Methods.doc).
The data presented were obtained in three independent
experiments with fibroblasts from two keloid prone indi-
viduals (labeled as keloid D and keloid T), as well as with
fibroblasts from one non-affected individual. Similar re-
sults (not presented here) were found with fibroblasts
from other keloid donors and nonaffected individuals.
Results and Discussion
Growth rates and morphologic characteristics of palmo-
plantar and non-palmoplantar fibroblasts
The proliferation of preconfluent fibroblasts grown on tis-
sue culture plastic was measured as a function of 3H-thy-
midine incorporation into TCA-precipitates. As shown in
Fig. 1, fibroblasts, derived either from the palmar skin of
keloid-forming donors or the plantar skin of nonaffected
donors, incorporated more 3H-thymidine than did those
isolated from keloid or normal nonglabrous trunk skin.
This apparent difference in proliferation rate is consistent
with the microscopic observation (data not shown) that
palmoplantar (PP) fibroblasts reached confluence 2–3
days earlier than did the non-palmoplantar (non-PP) cul-
tures, when plated at the same density. Earlier work from
other laboratories had indicated that normal fibroblasts
grew more quickly [42], similarly [6,43] or more slowly
[16,34] than did keloid fibroblasts. Such variations may
reflect differences in culture conditions at the time of as-
say. For example, in confluent cultures the growth rate of
PP fibroblasts slows to less than that of non-PP fibroblasts
(results not shown).
Figure 1
3H-thymidine incorporation in keloid and normal
nonpalmoplantar fibroblasts compared to palmo-
plantar fibroblasts.
Fibroblast source
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Size and granularity in fibroblast cultures from different origin. A/: Forward (FSC-H) and side scattering (SSC-H) data
from FACS analysis of cultures grown with serum for three days after confluence. B/: Difference in size (the total percentage of
cells with forward scattering in the Upper and Lower Right quadrants) and granularity (the total percentage of cells with side
scattering in the Upper Left and Right quadrants). The FSC and SSC intervals are arbitrarily chosen.
Keloid fibroblasts                          Nonplantar fibroblasts
Palmar fibroblasts                               Plantar fibroblasts
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guished by a paucity of fibroblasts with high granularity
(side scattering), a characteristic often associated with the
elaboration of RER (rough endoplasmic reticulum) [44].
In both confluent and post-confluent cultures, the popu-
lations of cells with the highest granularity were found in
the non-PP isolates (keloid and nonplantar). The differ-
ences in proliferation rate and granularity predict and are
consistent with differences in protein expression [[36], be-
low]. Palmar, but not plantar, isolates were also found to
have smaller cell size (judged by forward scattering, Fig.
2A,2B and light microscopy (data not shown)).
TGFβ1 receptor and ED-A fibronectin in palmoplantar and 
non-palmoplantar fibroblasts
Earlier work demonstrated that palmoplantar fibroblasts
express less α-SMA than do keloid or to a lesser extent nor-
mal non-palmoplantar fibroblasts [36]. As TGFβ1 is a
positive regulator of α-SMA, these observations could re-
flect the relative levels of active TGFβ1 or the levels of
those proteins responsible for the transduction of its sig-
nal. We therefore measured the expression of α-SMA to-
gether with of the expression of those proteins
participating in the initial signal transduction event:
TGFβ1, its type II receptor (TGFβ1-RII), and ED-A fi-
bronectin. No consistent differences were detected in the
levels of intracellular or secreted, latent or active TGFβ1
(data not shown). However, as shown in Figs. 3 (for FACS
analysis examples, please, see additional file 1: Additional
data #1.ppt), the expression of both TGFβ1-RII and ED-A
fibronectin was lower in PP cultures than in non-PP cul-
tures. In contrast to previous reports [21], the level of
TGFβ1-RII in keloid fibroblast cultures was similar to that
in plantar cultures or even lower than that of normal non-
plantar fibroblast cultures – Fig. 3. α-SMA content corre-
lated most closely with the levels of ED-A fibronectin (Fig.
3). For keloid fibroblasts, the size and granularity of the α-
SMA expressing cells was similar to those expressing ED-A
fibronectin rather than TGFβ1-RII (not shown, please, see
additional file 2: Additional data #2.ppt). Cells with the
highest granularity expressed TGFβ1-RII, while cells with
medium granularity had high levels of α-SMA and ED-A
fibronectin (not shown, please, see additional file 2: Ad-
ditional data #2.ppt). Together with our previous results
demonstrating higher levels of thrombospondin-1 in kel-
oid fibroblasts [36], the data suggest that keloid fibroblasts
(and to a lesser extent normal non-PP fibroblasts) appear
primed to more effectively transmit the TGFβ1 signal and
thereby to express the myofibroblast phenotype.
Myofibroblast formation and apoptosis
Resolution of normal dermal wound healing requires a
decrease in scar cellularity so as to prevent excessive colla-
gen accumulation and wound contraction. The reduction
in cellularity occurs through the process of apoptosis in fi-
broblasts [28] and possibly myofibroblasts ([29], and see
below). To determine the extent to which the myofibrob-
last phenotype is expressed and the extent to which myofi-
broblasts undergo apoptosis, α-SMA content and
apoptosis were measured simultaneously using two-color
FACS analyses. Shown in Fig. 4 are the four classes of fi-
broblasts which could be distinguished: α-SMA-, apopto-
sis- (lower left quadrant LL, "naïve" fibroblasts); α-SMA+,
apoptosis- (upper left quadrant UL, myofibroblasts); α-
SMA-, apoptosis+ (lower right quadrant LR, apoptotic fi-
broblasts) and α-SMA+, apoptosis+ (upper right quadrant
UR, apoptotic myofibroblasts). The analyses by FACS of
fibroblasts grown directly on tissue culture plates (monol-
ayer cultures) or on collagen I revealed several differences
between PP and non-PP cultures in response to conflu-
ence, serum, TGFβ1 and embedding within collagen gels
(Figs. 5,6,7).
"Monolayer" cultures
Comparisons of confluent cultures with three-day post-
confluent cultures revealed an increase in α-SMA levels in-
dependent of media serum content – Fig 5A (for examples
of the actual FACS analyses, please, see additional file 3:
Additional data #3.ppt). The postconfluent PP cultures
had considerably less α-SMA than either the keloid or the
normal non-PP control (Fig. 5A). These results are consist-
ent with data reported for palatal fibroblasts [43], but con-
trast with observations on corneal fibroblasts [45]. In the
Figure 3
TGFβ1 Receptor II, ED-A fibronectin and α-Smooth
Muscle Actin (α-SMA) in fibroblasts from different
body sites. The product of [Percentage immunopositive
cells]*[GeoMean of the fluorescence distribution – back-
ground] is used to estimate the antigen content. The scale to
the right is for the ED-A fibronectin only. (For examples of
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lated the most α-SMA – Fig. 5A.
To determine whether TGFβ1 could eliminate differences
in α-SMA levels between PP and non-PP fibroblasts, cul-
tures were incubated at confluence for three days with se-
rum-free or serum-containing media supplemented with
0 ng/ml or 10 ng/ml active TGFβ1, and α-SMA and apop-
tosis were evaluated (Fig. 5A,5B; for examples of actual
FACS analyses, please, see also additional files: Additional
data #3.ppt). All fibroblast cultures responded to TGFβ1
with an increased accumulation of α-SMA, although the
α-SMA content of PP cultures again remained lower than
either the keloid or the normal non-PP isolates. While the
two keloid and palmar pairs differed in absolute α-SMA
levels, the difference between paired keloid and palmar
samples was statistically significant (p = 0.05) (not
shown, please, see also additional file 4: Additional data
#4.ppt). In both paired samples keloid fibroblasts con-
tained more α-SMA than did palmar fibroblasts. Lower
concentrations of TGFβ1 (2.5 ng/ml and 5 ng/ml) were
also found (data not shown) to be equally effective in up-
regulating α-SMA in accordance with other data [45,46].
Simultaneous evaluation of apoptosis was carried out. Se-
rum withdrawal increased the percentage of apoptotic
cells (Fig. 5B; for examples of actual FACS analyses,
please, see additional files: Additional data #3.ppt) – a
considerable number of which were α-SMA positive. The
impact of serum withdrawal was found to be greater in PP
cultures than in non-PP cultures (Fig. 5B). In addition,
during serum starvation about 10% of PP fibroblasts de-
tached and were found floating. FACS analysis demon-
strated that these cells were all apoptotic (not shown, see
also [36]). Although TGFβ1 acted anti-apoptotically in PP
cultures (palmar and normal plantar fibroblasts) and pre-
vented the shedding of cells into the media, its effect was
dissimilar in non-PP cultures, where TGFβ1 had either no
impact (keloid T and normal nonplantar fibroblasts) or
was pro-apoptotic (keloid D cultures).
In the presence of serum, TGFβ1 acted anti-apoptotically
only on the normal plantar cultures and was without ob-
servable effect on the palmar cultures (Fig. 5B). However,
the addition of TGFβ1 to the non-PP cultures always re-
sulted in increased apoptosis in the presence of serum: in
keloid D small increases were observed and in keloid T
and in normal nonplantar cultures large increases were
observed.
Thus, in contrast to the ability of TGFβ1 to induce the ex-
pression of α-SMA in all fibroblast cultures, its effect on ap-
optosis was fibroblast-origin dependent.
Impact of collagen on levels of α-SMA and apoptosis in fi-
broblasts
Measurements were made of the α-SMA content and ap-
optotic status of fibroblasts embedded within attached or
detached(relaxed) gels incubated for three days in the
presence or absence of serum and TGFβ1 (Figs. 6 and 7).
The data were compared with those obtained prior to em-
bedding and with three day post confluent monolayer cul-
tures (Fig. 5A,5B). In attached gels, α-SMA content
modestly increased in PP fibroblasts (e.g. UL in 6a', Fig.
7A; for the FACS at confluence see examples in Additional
data #3). TGFβ1 further induced the expression of α-SMA
(e.g. UL+UR in Fig. 6B, Fig. 7A), although in no instance
were the levels increased to those observed in the three
day postconfluent cultures (Fig 5A). In contrast to PP fi-
broblasts the α-SMA content of keloid and normal non-
PP fibroblasts did not increase post collagen embedding.
Even TGFβ1 was modestly effective at increasing α-SMA
levels in keloid and normal non-PP fibroblasts (Fig. 7A).
The inability of keloid fibroblasts to respond with in-
creased α-SMA to TGFβ1 may be a consequence of their
ability to initiate gel contraction (only the central portion
Figure 4
Schematic of the FACS analysis Two color FACS analy-
sis of the levels of: apoptosis, measured by the TUNEL assay
(using fluorescein-dUTP) – FL1; α-SMA – FL2, using a Phyco-
erythrin-conjugated secondary antibody. Quadrants are
defined by background fluorescence of fluorescein and phy-
coerythrin. Lower Left (LL) quadrant – α-SMA-negative, non-
differentiated, non-apoptotic ("Naïve") fibroblasts; Upper
Left (UL) quadrant – non-apoptotic cells with higher α-SMA
content – non-apoptotic myofibroblasts); Upper Right (UR)
quadrant – apoptotic myofibroblasts; Lower Right (LR) quad-
rant – apoptotic fibroblasts who have either lost the myofi-
broblast phenotype or have not developed it at all. Apoptotic
fibroblasts eventually detach from the plate. Question marks
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Effect of serum and TGFβ1 on α-SMA and on apoptosis in fibroblasts. Fibroblasts were analyzed as described in Fig-
ure 4. (for examples of actual FACS scans, please, see additional file 3: Additional data #3.ppt). Also A/ α-SMA: The product
of [Percentage immunopositive cells]*[GeoMean of the fluorescence distribution – background] was used to estimate the α-
SMA content and includes contributions from both viable myofibroblasts (UL quadrant, see Fig. 4) and apoptotic myofibrob-
lasts (UR quadrant, see Fig. 4). The data are average of three experiments with two keloid-palmar pairs and one nonplantar-
plantar pair of fibroblast cultures. B/ Apoptosis: The product: [Percentage apoptotic fibroblasts]*[GeoMean TUNEL fluores-
cence – background] was used to estimate the apoptotic status of the culture with contributions from both fibroblasts (LR)
and myofibroblasts (UR). Average of data from three experiments with: two keloids (plotted separately), two palmar cultures
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gels there was no detectable increase in α-SMA in palmar
fibroblasts and a decrease in α-SMA in keloid fibroblasts.
Most of the fibroblasts were apoptotic (e.g. LR in Figs. 6c,
6c'). Similar results were obtained with normal PP and
normal non-PP fibroblasts.
The impact of ECM (collagen) on α-SMA accumulation
was also evaluated in two other experimental settings (da-
ta not shown): monolayer cultures of fibroblasts grown
with ascorbic acid to permit collagen secretion, and mon-
olayer cultures of fibroblasts grown on collagen I coated
plates. In both settings α-SMA levels were reduced com-
pared to controls grown on noncoated tissue culture plas-
tic or without ascorbic acid (see similar results in [47]).
Taken together these results suggest that the presence of
collagen and the stressed to relaxed state transition of the
ECM alters or dominates TGFβ1 signal transduction (see
also [25]). The corresponding reduction in α-SMA is in
agreement with recent in vivo data on splintered vs. un-
splintered rat wounds [48], but differs from in vitro results
on human gingival fibroblasts [49].
When apoptosis was evaluated, it was found to increase
significantly in all fibroblast types within attached gels by
comparison to the input fibroblasts (Fig. 7B). Many of the
apoptotic cells were α-SMA positive (see UR in Fig. 6).
Previous reports indicating a lack of apoptosis in attached
gels were based on analyses using an ELISA that did not al-
low detection of events in apoptosis which precede the
formation of a nucleosomal ladder [50]. Experiments
aimed at evaluating keloid fibroblasts in attached gels
were confounded by the ability of these fibroblasts to con-
tract the gels and cause partial gel relaxation with concom-
Figure 6
FACS analyses of keloid and palmar fibroblasts embedded in collagen I gels. Keloid (a-c) and palmar (a'-c') fibrob-
lasts in gels incubated for three days either with serum (a, a') or with serum and TGFβ1 (b, b', c, c'). Attached* – gels with kel-
oid fibroblasts (a, b) were partially detached, self shrinking and remaining attached only in the center, while the gels with the
palmar fibroblasts were fully attached – (a' b'). Relaxed gels (c, c') were fully floating in the media.
Keloid fibroblasts in collagen I gels
Palmar fibroblasts in collagen I gels
a/ with serum (attached*) b/ with serum+TGFβ1(attached*) c/ with serum+TGFβ1(relaxed*)
c’/ with serum+TGFβ1(relaxed*)b’/ with serum+TGFβ1(attached)a’/ with serum (attached)Page 8 of 13
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Myofibroblasts and apoptosis of fibroblasts embedded in attached collagen I gels. Summary of all results for fibrob-
lasts grown up to confluence, embedded in collagen gels and harvested after three days. Analysis was as described in Fig. 4 and
5. A/α-SMA. The data for the keloid and palmar cultures are average from three experiments with two keloid-palmar pairs
and three experiments with a nonlantar-plantar pair; B/Apoptosis. Results are averages of three experiments. The average for
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fibroblasts did not readily undergo apoptosis in response
to serum-starvation in monolayer cultures, they under-
went the most apoptosis once embedded in attached gels,
due to the self-relaxation of these gels. At the same time
and under the same conditions the corresponding palmar
fibroblasts showed lower apoptosis levels (Figs. 6b, 7B).
TGFβ1 had minor and variable effect on apoptosis in at-
tached gels (Fig. 7B).
Upon gel relaxation (i.e. after full detachment) apoptosis
significantly increased (LR in Fig. 6c, 6c'). In contrast to
monolayer cultures exogenous TGFβ1 did not alter apop-
tosis (Fig. 6c, 6c', data not shown). This is consistent with
other data on gel-embedded foreskin fibroblasts, which
led to the conclusion that prior differentiation into myofi-
broblasts is not required for apoptosis in granulation tis-
sue [41]. Our data on attached gels (when α-SMA positive
fibroblasts were present even without exogenous TGFβ1)
demonstrated that a considerable percentage of myofi-
broblasts underwent apoptosis (Fig. 6a, 6a', 6b, 6b', and
data not shown). The decrease in percentage of myofi-
broblasts in the relaxed gels containing keloid fibroblasts
(compare Fig. 6b, 6b' with Fig. 6c, 6c') may be due to a
gradual turnover of α-SMA in the cells undergoing apop-
tosis. In the scheme presented in Fig. 4 this process would
correspond to the phenotypic conversion of apoptotic
myofibroblasts (UR) to apoptotic fibroblasts (LR) by pro-
teolysis of α-SMA. However, during granulation tissue re-
modeling in vivo, decreased cellularity may be the result
of apoptosis of fibroblasts and myofibroblasts [29].
Our findings showed that reduction of tension in the ECM
provokes apoptosis and reduces α-SMA; as human dermal
myofibroblasts readily undergo apoptosis in response to gel
relaxation (or wound contraction) their absence from the
neodermis of a healed wound is likely the result of apoptosis.
Conclusions
There are several issues addressed for the first time in this
paper relating apoptosis and myofibroblast formation in
human dermal fibroblasts.
Phenotypic differences exist among fibroblasts from
different dermal origin
- non-palmoplantar (non-PP) or palmoplantar (PP) –
normal (nonplantar, plantar, palmar from keloid patient
biopsies) or abnormal (from keloid biopsies). Our work
demonstrated that keloid fibroblasts had higher cellular
levels of several members of the TGFβ1 pathway (TGFβ1-
RII and ED-A fibronectin; also thrombospondin-1 [36]).
In addition TGFβ1 effects on apoptosis differed in non-PP
vs. PP fibroblasts. TGFβ1 acted pro-apoptotically on non-
PP fibroblasts and anti-apoptotically on PP fibroblasts. It
had a pro-apoptotic effect on myofibroblasts. These re-
sults suggest that, at least in part, the difference between
keloid and palmar fibroblasts may be due to particular
levels of TGFβ1-pathway related proteins at nonglabrous
vs. glabrous sites.
Effect of tension in the ECM
- We found that matrix tension was dominant over TGFβ1
in determining myofibroblast formation and apoptosis
levels. Apoptotic cells predominated in relaxed gels, inde-
pendent of TGFβ1 availability. Keloid fibroblasts, once
embedded in collagen gels – an environment exerting less
tension on the fibroblasts – were more apoptotic than the
corresponding palmar fibroblasts. This difference may be
attributed to the ability of keloid fibroblasts to contract
the collagen gel.
For the exuberant accumulation of collagen during keloid
formation, matrix relaxation-induced apoptosis must be
delayed. This suggests that body-site specific keloid for-
mation may be dependent on the difference in the devel-
opment and resolution of tension in the wound bed at
nonglabrous vs. glabrous sites in keloid prone patients.
Thus a necessary requirement for keloid formation will be
maintenance of tension to prevent (delay) apoptosis. This
gives sufficient time for the fibroblasts to express and de-
posit collagen in the ECM. With the accumulation of col-
lagen the tension experienced by the fibroblasts in the
keloid will be reduced and apoptosis initiated. According
to our data reduced tension would lead to lowering of the
α-SMA level in the keloid.
Although myofibroblasts were not detected in vivo [51],
the propensity of keloid fibroblasts to express α-SMA in
vitro and the loss of this protein upon matrix contraction
(gel relaxation) do not allow one to dismiss a role for my-
ofibroblasts in keloids. Rather it may be necessary to re-
evaluate α-SMA expression in the early stages of keloid de-
velopment, when tension within the wound bed is high.
Usually the studied keloids are at least several months old
and may have had enough time for tension relaxation and
loss of α-SMA. Interestingly, keloids in some Caucasian
patients were found to contain α-SMA positive fibroblasts
[52]. Many of the α-SMA positive cells were spindle-
shaped, which suggests that these cells experienced out-
side tension. Furthermore, persisting tension in the
wound bed may explain why hypertrophic scars maintain
the myofibroblast phenotype long after wound closure.
Fibroblasts at glabrous sites (palms, soles) do not pro-
mote keloid formation consistent with an earlier reduc-
tion in cellularity, necessary for a normal wound healing.
It is noteworthy that tension/mechanical loading is exert-
ed through the ECM by fibroblasts expressing a "synthet-Page 10 of 13
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phenotype, keloid formation at glabrous sites may be fur-
ther limited by the PP fibroblast requirement for higher
and/or more sustained levels of TGFβ1.
Clinical applications of pressure dressings that relieve
wound bed tension are traditionally used to prevent aber-
rant scar formation during burn wound healing. Compar-
isons of non-pressure vs. pressure-treated hypertrophic
scars have shown that pressure supports the disappear-
ance of α-SMA expressing myofibroblasts [54]. The data
presented in this work suggest that body site differences in
fibroblasts and wound tension are critical determinants of
the keloid-less healing of palmoplantar wounds of keloid-
prone individuals.
List of abbreviations
ECM – extracellular matrix; non-PP – non-palmo-plantar,
PP – palmo-plantar; Quadrants in the FACS plot: LL –
lower left, UL – upper left; LR – lower right; UR – upper
right; α-SMA – alpha smooth muscle actin; TCA – tri-chlo-
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